DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGKV6D-21; IGLV3-12; IGKV1D-33; IGKV2D-24; TRAV2; IGLV3-21; IGKV3-11; IGLV7-46; IGLV5-45; IGLV4-60; IGLV3-19; IGLV9-49; IGLV2-14; IGKV6-21; IGKV1-33; IGKV1-39; IGLV5-37; IGKV1D-39; TRDV2; IGKV2D-40; IGKV3-7; IGKV1-9; IGKV2D-29; IGLV4-3; IGKV1D-13; IGLV4-69; IGLV2-23; IGKV1D-16; IGKV2D-30; IGKV3-20; IGKV2-24; IGLV2-8; IGKV1-8; IGKV4-1; IGKV1-16; IGKV1D-17; TRAV14DV4; IGLV3-16; IGLV6-57; IGLV2-11; IGKV3D-11; TRDV1; IGKV1-27; IGKV1-6; IGKV1-12; IGKV3D-15; IGKV5-2; IGKV1-17; IGLV1-40; TRAV38-2DV8; IGKV1D-12; IGLV3-1; IGLV1-44; IGKV3D-20; TRAV18; IGKV1-5; IGLV3-25; IGLV8-61; IGLV2-18; IGLV1-36; IGLV7-43; IGLV3-9; IGLV3-27; IGKV2-30; TRAV38-1; IGKV2-29; TRDV3; TRAV9-2; TRAV19; IGLV1-47; IGKV3-15; IGLV3-10; IGKV1D-43; IGLV10-54;	GO:0002377~immunoglobulin production	74	107	69.1588785046729	0	0	0	0	0	0	0
up	IGHV3-11; IGHV4-39; IGHV3-74; IGHV1-69; IGLL5; IGHG2; IGHV3-30; IGHV1-2; IGHV4-4; IGHV3-43; IGHV4-28; TRDC; IGLC6; IGHV1-46; IGHV3-64; IGHV3-66; IGHV3-72; IGHV1-45; TRBC2; IGHA2; IGHV1-3; IGHV3-35; IGHV1-18; IGHV3-15; IGHV3-49; IGHV1-69-2; IGHV3-20; IGHV3-21; IGLC7; IGLC3; IGHV3-23; IGHV3-13; IGHV2-70; IGHV3-53; IGHG3; IGHV3-7; IGHV1-58; IGHV4-61; IGHV2-5; IGHD; IGHV2-26; TRBC1; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV6-1; IGHV4-31; IGHV3-48; IGHV1-24; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	53	99	53.5353535353535	0	0	0	0	0	0	0
up	IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; FCN1; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	58	92	63.0434782608696	0	0	0	0	0	0	0
up	TNFRSF13B; LILRA1; IFNG; IL2RA; CD3D; INHBA; CD3G; SAG; CXCR1; LAMA1; KLRC1; CXCR3; CCR5; ADGRE1; LILRB2; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; TRBV6-1; TRBV7-1; TRBV27; TRBV6-8; TRBV17; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV5-7; TRBV30; TRBV10-2; TRBV6-7; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV16; TRBV23-1; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; PDCD1LG2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	66	268	24.6268656716418	0	0	0	0	0	0	0
up	IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; IGLC6; IGLC2; IGLC3; FCGR2A; IGHV1-2; FCGR2B; NCKAP1L; IGLV3-21;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	61	135	45.1851851851852	0	0	0	0	0	0	0
up	LYZL6; HP; ELANE; IRF8; CEBPE; TLR9; STAB1; IGHV3-48; IGHV6-1; IGHG2; IGLC3; IGHG3; IGHV1-46; IGHV3-53; IGHV3-13; IGLC6; IGHV1-24; TRBC1; IGHV3-73; IGHV1-2; TRBC2; IGHV3-30; IGHV1-45; IGHA2; IGLC2; IGHV3-72; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV3-74; IGHV1-18; IGHV2-70; IGHV3-7; IGHV1-58; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-66; IGHV3-64; IGHV3-35; IGHV3-23; IGHV1-69; IGHV1-69-2; IGHV4-31; IGLC7; TRDC; IGHV3-20; IGHV4-61; IGHV3-43; IGKC; IGHV4-39; IGHV4-28; IGHV2-26; IGHV4-4; IGHV3-21; IGHV3-11; IGHV4-59; IGHV1-3; IGHV3-33;	GO:0042742~defense response to bacterium	60	216	27.7777777777778	0	0	0	0	0	0	0
up	IGKV2D-30; TRAV19; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; CD300LB; NCR3; TYROBP; LILRA1; NCR1; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; TRBV12-3; TRAV8-4; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; TRBC1; IGLV7-43; CD3D; IGKV1-16; IGKV1D-39; IGKV3-11; TRBV7-9; TRAV29DV5; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; IGLC6; IGLC2; IGLC3; CD8B; CD19; IGHV1-2; KLRC1; CD40LG; FCGR2B; ICAM3; KIR2DL1; KIR2DL3; KIR3DL1; KIR3DL2; IGLV3-21; CD300E; TREML2; LAIR2; CLEC4G; TREML4; CD300LD; LILRB2; LILRB1; CD300LF; KIR2DL4; CD300A; ICAM5; SIGLEC7; BTNL8; BTNL3; BTN1A1;	GO:0050776~regulation of immune response	94	216	43.5185185185185	0	0	0	0	0	0	0
up	MS4A1; CD19; CTLA4; MNDA; NCKAP1L; IGHV4-34; IGHV4-4; IGHV4-61; IGHV3-33; IGHV3-11; IGHV3-72; IGHV3-21; IGHV4-28; IGHV4-39; IGHV1-69-2; IGHV1-2; IGHV2-70; IGHV2-5; IGHV2-26; IGLL5; IGLC3; IGHV3-35; IGHV3-43; IGHV3-30; IGHV3-13; TRBC2; IGHV5-51; CD79B; IGHG2; IGHV3-23; IGHV1-3; IGHV1-69; IGHV3-73; IGHV1-46; IGLC6; IGHV4-59; IGHV3-64; IGHV6-1; IGHV1-45; IGHG3; IGHV1-18; IGHV1-24; IGLC7; TRBC1; IGHA2; IGHV3-74; IGHV3-20; TRDC; IGHD; IGHV3-15; IGHV3-66; IGHV3-48; IGLC2; IGHV4-31; IGHV1-58; IGHV3-53; IGHV3-49; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	59	125	47.2	0	0	0	0	0	0	0
up	TLR9; IGHV1-45; IGHV2-26; IGHV3-53; IGHG3; IGHV3-49; IGHV1-69-2; IGLC7; IGLC3; IGHV3-15; IGHV4-39; IGHV3-64; IGHV4-28; IGHV2-70; IGHV3-21; IGHD; IGHV4-59; IGHV1-69; IGHV4-4; IGHV3-73; IGHV3-23; IGHV3-13; IGHV1-2; TRBC1; IGHV1-18; IGLL5; IGHV1-24; IGHV3-72; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV3-20; IGHV1-46; IGLC6; IGHV4-31; IGHV5-51; IGHV4-61; IGHV1-3; IGHV6-1; IGHV4-34; IGHV3-66; IGHV1-58; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-35; IGHV3-30; IGHV3-43; IGHV2-5;	GO:0050871~positive regulation of B cell activation	54	98	55.1020408163265	0	0	0	0	0	0	0
up	IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; JCHAIN; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; GYPA; FN1; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; GYPB; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; DBH; CD48; IGLC6; IGLC2; IGLC3; IGHV1-2; ITGA3; CEACAM8; L1CAM; CEACAM3; IGLV3-21; SIRPG; CD84;	GO:0050900~leukocyte migration	68	193	35.2331606217617	0	0	0	0	0	0	0
up	TYROBP; CTLA4; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	6	16	37.5	0.0001179902973798	0.00975250837308207	0.279519014492746	0.28282274281938	0.278929063005847	0.279519014492746	0.0815250939069716
down	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	7	9	77.7777777777778	0.0001246283730576	0.0478296000601057	0.429469373556491	0.430466400540952	0.428596974945088	0.429469373556491	0.417296456853408
up	TARM1; FCN1; SIGLEC5; TYROBP; FCGR3B; TRPM2; HP; PLAU; ORM1; LTF; ELANE; CTSG; RNASE2; FCGR2A; RNASE3; DEFA4; BPI; CD53; ORM2; AZU1; MMP8; FCAR; CXCR1; CEACAM8; CEACAM3; MNDA; P2RX1; HK3; NCKAP1L; SIGLEC14; CLEC12A; LILRB2; CLEC4C; MS4A3; ADGRE3; RETN; CD300A;	GO:0043312~neutrophil degranulation	37	483	7.66045548654244	0.0001591730728242	0.0127179285186539	0.376921836447714	0.381537855559616	0.37564845186512	0.376921836447714	0.106314219595768
down	UGT1A9; UGT2B7; UGT1A6; UGT1A1; UGT1A4; UGT1A3; UGT1A7; UGT1A10;	GO:0052695~cellular glucuronidation	8	14	57.1428571428571	0.00019120074548817	0.0600370340832865	0.65849536746127	0.660407374916152	0.656965761497365	0.65849536746127	0.523802029945039
up	FN1; SERPINE1; ITGB4; LAMA1; ITGA3; LOX; ICAM3; MFAP2; ITGAD; LAMB3; LAMC2; COL4A6; COL19A1; LAMA3; PXDN; ICAM5; NR2E1; MMP23B; COL22A1; MMP8; MMP17; POSTN;	GO:0030198~extracellular matrix organization	22	230	9.56521739130435	0.00021395859574091	0.0165438307739024	0.506439996118746	0.512858753990974	0.482262674800023	0.506439996118746	0.13829645726284
up	HBA1; PXDN; HBG2; HBZ; HBD; HBM; HBG1;	GO:0042744~hydrogen peroxide catabolic process	7	28	25	0.00026398470492694	0.0191748890215117	0.624323827152225	0.632771337709887	0.55304795682195	0.624323827152225	0.160290518944766
up	TRPM2; GATA1; FLT3; LILRB1; BATF3;	GO:0097028~dendritic cell differentiation	5	12	41.6666666666667	0.00030278411909634	0.0213462803962923	0.715781657543758	0.725773533473937	0.600420908168051	0.715781657543758	0.178442042528829
down	MT1X; MT1E; MT1B; MT1A; MT4; MT1H; MT1M; MT1G;	GO:0010273~detoxification of copper ion	8	16	50	0.00038040523301663	0.0939685103428856	1	1	0.999999999042763	0.999999999042763	0.819842239378999
down	CLDN7; CLDN14; CLDN1; CLDN8; CLDN12; CLDN17; CLDN18; CLDN2; CLDN10;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	9	21	42.8571428571429	0.00040267616283573	0.0939685103428856	1	1	0.999999999042763	0.999999999042763	0.819842239378999
down	CCL22; CXCL11; WNT9B; EFNA2; CXCL13; CXCL14; CXCL10; INHA; EDN1; PGR; S100A9; GJB1; CGB7; BMP2; EDN3; GJA1; ADCYAP1; NTF3; GJB2; EFNA3; CCL18; CX3CL1; CXCL9; IL18; GPNMB; IL17A; CCL17; TFAP2C; FGF14; TBX5; FGF20; GJB4; IL36G; GPR101; ADRB3; DRD1; ADRA2C; FGFBP1;	GO:0007267~cell-cell signaling	38	230	16.5217391304348	0.00042444233568728	0.0939685103428856	1	1	0.999999999042763	0.999999999042763	0.819842239378999
down	CFTR; AQP1; SCNN1A; SCNN1B; SCNN1G; AQP4;	GO:0050891~multicellular organismal water homeostasis	6	8	75	0.00044563319865365	0.0939685103428856	1	1	0.999999999042763	0.999999999042763	0.819842239378999
up	LILRA5; IFNG; ORM1; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	6	22	27.2727272727273	0.00049192770824169	0.0327541865737592	1	1	0.765439514024071	0.999999225924548	0.273805264668366
up	CCL24; TSHB; WNT1; INHBA; PTHLH; GATA1; SSTR3; XCL1; FASLG; CCR5; CRB1; GRAP; FAT1; LILRB2; FCRL2; STAB1; SIRPG; CCL26; ADRA1D; FGFBP2; DRD3;	GO:0007267~cell-cell signaling	21	230	9.1304347826087	0.00051760078639884	0.033532137432379	1	1	0.781059586675852	0.999999225924548	0.280308465114627
down	PRSS38; PRSS37; TRABD2B; CLCA1; ADAMDEC1; TMPRSS2; KLK10; TMPRSS11D; KLK8; REN; MMP7; C1S; RBP3; CTSE; CTRB1; ENDOU; CASP14; MMP12; KLK7; RHBDL3; TMPRSS15; WFDC2; HABP2; PRSS8; MMEL1; CPZ; PM20D1; GGT6; CASP12; TMPRSS11A; TMPRSS11F; TMPRSS11B; ADAMTSL2; TMPRSS12; DPP10; ADAMTS19; TMPRSS13; ADAM33; PRSS22; MMP27; RHBDL2; KLK14; KLK11; KLK12; KLK13; TMPRSS11E; KLK5; CAPN8; PGA5; CAPN9; TPSAB1; CPA6; CPO; TPSB2; CAPN6; PLAT; PGA3; PGC; CPA4; TPSD1; TPSG1;	GO:0006508~proteolysis	61	436	13.9908256880734	0.00059368225236666	0.113921027759693	1	1	0.999999999042763	0.999999999042763	0.993920944048835
up	APOA2; ELANE; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	5	15	33.3333333333333	0.00069112503437807	0.0435954396685325	1	1	0.875098256407576	0.999999225924548	0.364431608457017
down	MT1A; MT1E; MT1B; MT1G; MT1H; MT1X; PTK6; MT1M;	GO:0045926~negative regulation of growth	8	18	44.4444444444444	0.00069922587395876	0.127111903613346	1	1	0.999999999042763	0.999999999042763	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00094705059410038	0.0582071865143237	1	1	0.973343394934534	0.999999225924548	0.486577008202166
down	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.0009999239604056	0.16256541221145	1	1	0.999999999042763	0.999999999042763	1
up	TRPM2; CXCR1; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	5	17	29.4117647058824	0.00110336153653379	0.0661189400767872	1	1	0.999999225924548	0.999999225924548	0.552714500985965
up	FN1; INHBA; MMP8; HMGA2; LAMB3; LAMA3;	GO:0035987~endodermal cell differentiation	6	28	21.4285714285714	0.00145134734419483	0.0825235024463028	1	1	0.999999225924548	0.999999225924548	0.689846758300284
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.00161138439826547	0.085833075614274	1	1	0.999999225924548	0.999999225924548	0.717512795896884
up	TAL1; SOX8; GCM1;	GO:0060018~astrocyte fate commitment	3	4	75	0.00161138439826547	0.085833075614274	1	1	0.999999225924548	0.999999225924548	0.717512795896884
up	INHBA; ITGB4; ITGA3; HMGA2;	GO:0048333~mesodermal cell differentiation	4	11	36.3636363636364	0.00188081184112354	0.0980066518081115	1	1	0.999999225924548	0.999999225924548	0.819276558040944
up	DBH; HRH2; HRH1; ADRA1D; AVPR2; AVPR1A;	GO:0045907~positive regulation of vasoconstriction	6	30	20	0.00197296462519037	0.100621195884709	1	1	0.999999225924548	0.999999225924548	0.841132571203344
down	APOA1; APOE; APOC1; APOC3; APOA4; ABCA12;	GO:0033700~phospholipid efflux	6	12	50	0.00208364534851202	0.257032536920018	1	1	0.999999999042763	0.999999999042763	1
down	EDN1; EDN3; EDN2; EDNRB;	GO:0014826~vein smooth muscle contraction	4	4	100	0.00219847148604924	0.261845534924623	1	1	0.999999999042763	0.999999999042763	1
up	ITGB4; LAMB3; LAMC2; LAMA3;	GO:0031581~hemidesmosome assembly	4	12	33.3333333333333	0.00243425357373717	0.119079710535673	1	1	0.999999225924548	0.999999225924548	0.995434632041004
up	LTF; GATA1; SOX8; TMEM119;	GO:0033690~positive regulation of osteoblast proliferation	4	12	33.3333333333333	0.00243425357373717	0.119079710535673	1	1	0.999999225924548	0.999999225924548	0.995434632041004
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0025068663505281	0.120179172844317	1	1	0.999999225924548	0.999999225924548	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	7	18	38.8888888888889	0.00275904846632269	0.307411400086405	1	1	0.999999999042763	0.999999999042763	1
down	DSP; DES; KRT9; KRT20; KRT2; KRT17; TCHH;	GO:0045109~intermediate filament organization	7	18	38.8888888888889	0.00275904846632269	0.307411400086405	1	1	0.999999999042763	0.999999999042763	1
up	CEACAM4; ICAM3; IRF8; SLAMF1; CEBPE; PLD4; ICAM5; ELANE;	GO:0006909~phagocytosis	8	57	14.0350877192982	0.0027906829819363	0.131162100151006	1	1	0.999999225924548	0.999999225924548	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	7	19	36.8421052631579	0.00351793047400228	0.353472210125947	1	1	0.999999999042763	0.999999999042763	1
down	APOA1; APOE; APOC3; APOA4; GPIHBP1;	GO:0034371~chylomicron remodeling	5	9	55.5555555555556	0.00353499299169291	0.353472210125947	1	1	0.999999999042763	0.999999999042763	1
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00365644253360164	0.155381953557426	1	1	0.999999225924548	0.999999225924548	1
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.00365644253360164	0.155381953557426	1	1	0.999999225924548	0.999999225924548	1
up	HRH1; OPRM1; OPRD1; ANO1; F2RL3; P2RY12; NMUR1; ADRA1D;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	8	60	13.3333333333333	0.0037064798224048	0.155381953557426	1	1	0.999999225924548	0.999999225924548	1
down	APOE; EDN1; MIF; EDNRB;	GO:0032269~negative regulation of cellular protein metabolic process	4	5	80	0.0037071813943157	0.353472210125947	1	1	0.999999999042763	0.999999999042763	1
down	GJB5; GJB1; GJA1; GJB2;	GO:1905867~epididymis development	4	5	80	0.0037071813943157	0.353472210125947	1	1	0.999999999042763	0.999999999042763	1
up	AZU1; LOX; CCR6; CCR5; CXCR5; CXCR3; CCR10; CXCR1; CCR2;	GO:0060326~cell chemotaxis	9	74	12.1621621621622	0.00373830329866309	0.155381953557426	1	1	0.999999225924548	0.999999225924548	1
down	MT1A; MT1E; MT1B; MT1G; MT1H; MT1X; MT1M; MT4;	GO:0071294~cellular response to zinc ion	8	25	32	0.0037561408697131	0.353472210125947	1	1	0.999999999042763	0.999999999042763	1
down	SAA1; CCL2; EDN2; EDNRB; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	6	14	42.8571428571429	0.00378647127233933	0.353472210125947	1	1	0.999999999042763	0.999999999042763	1
up	P2RY10; GPR171; P2RY13; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.00385685763936905	0.155381953557426	1	1	0.999999225924548	0.999999225924548	1
up	IL27; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	4	14	28.5714285714286	0.00385685763936905	0.155381953557426	1	1	0.999999225924548	0.999999225924548	1
up	LILRA5; ORM1; ORM2; LILRA2; TLR8; NLRP7;	GO:0050718~positive regulation of interleukin-1 beta secretion	6	35	17.1428571428571	0.00388941060218839	0.155381953557426	1	1	0.999999225924548	0.999999225924548	1
up	SPTA1; HLA-DMB; CD40LG; AIF1; NCKAP1L; CLECL1; LILRB2; PDCD1LG2;	GO:0042102~positive regulation of T cell proliferation	8	61	13.1147540983607	0.00405834965417495	0.159473182312416	1	1	0.999999225924548	0.999999225924548	1
up	PF4; LTF; SEMG1; RNASE3; DEFA4; DEFA3; RNASE6; PF4V1;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	8	62	12.9032258064516	0.00443540161996048	0.171478349726537	1	1	0.999999225924548	0.999999225924548	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	8	26	30.7692307692308	0.00457274396800955	0.415638359618552	1	1	0.999999999042763	0.999999999042763	1
up	DBH; CRHBP; OPRM1; DRD3;	GO:0048149~behavioral response to ethanol	4	15	26.6666666666667	0.00474277154835301	0.180451165101622	1	1	0.999999225924548	0.999999225924548	1
down	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	5	10	50	0.0049562335668718	0.438944377948082	1	1	0.999999999042763	0.999999999042763	1
up	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.00507950558912118	0.184478407532174	1	1	0.999999225924548	0.999999225924548	1
up	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.00507950558912118	0.184478407532174	1	1	0.999999225924548	0.999999225924548	1
up	IFNG; CD40LG; IRF8; SCIMP; TLR9;	GO:0032735~positive regulation of interleukin-12 production	5	26	19.2307692307692	0.00539527316283039	0.193021936885141	1	1	0.999999225924548	0.999999225924548	1
down	A2ML1; SPINK4; CST4; CSTA; SLPI; CSTB; SPINK8; SERPINB3; SPINK7; WFDC2; CST6; CST9; ITIH5; WFDC5; WFDC12; CST11; CSTL1; SERPINB13; SERPINB7; SERPINB4; SERPINA11; SERPINB12; SERPINB5; SERPINB11;	GO:0010951~negative regulation of endopeptidase activity	24	148	16.2162162162162	0.00541628315770915	0.443309299941847	1	1	0.999999999042763	0.999999999042763	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036150~phosphatidylserine acyl-chain remodeling	7	21	33.3333333333333	0.00549948299347103	0.443309299941847	1	1	0.999999999042763	0.999999999042763	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	8	27	29.6296296296296	0.00551890558700041	0.443309299941847	1	1	0.999999999042763	0.999999999042763	1
down	APOA1; APOE; APOC3; HNF4A; IL18; GCKR; GPIHBP1; APOA4;	GO:0070328~triglyceride homeostasis	8	27	29.6296296296296	0.00551890558700041	0.443309299941847	1	1	0.999999999042763	0.999999999042763	1
up	CCL24; CDC42EP2; CSF3; ALOX15; NCKAP1L; LMOD2; CCL26;	GO:0030838~positive regulation of actin filament polymerization	7	51	13.7254901960784	0.00562094058634244	0.198138155668571	1	1	0.999999225924548	0.999999225924548	1
down	FGF10; APOE; BMP2; MIF; PLA2G2A; PDGFRA; ADCYAP1; FSHR; S100A7; KDR; PLA2G5; CASR; CX3CL1; GPNMB; SYT14P1; TNFAIP8L3; FFAR4; NPNT; SLC30A10; CCL19; GAREM1; FGF20; NOX4; CCL11; CCL1; CCL17; HMGB1P1; CCL22; CCL14; CCL2; CCL18;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	31	209	14.8325358851675	0.00568429134994175	0.444366949934235	1	1	0.999999999042763	0.999999999042763	1
down	TCF21; ID1; FOXF1; STRA6;	GO:0060426~lung vasculature development	4	6	66.6666666666667	0.00578937832861626	0.444366949934235	1	1	0.999999999042763	0.999999999042763	1
up	IFNG; AZU1; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	5	27	18.5185185185185	0.00620144321064942	0.212740920835532	1	1	0.999999225924548	0.999999225924548	1
up	GPR65; P2RY10; DRD3; F2RL3; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	6	39	15.3846153846154	0.00621270941113361	0.212740920835532	1	1	0.999999225924548	0.999999225924548	1
down	KRT18; KRT16; KRT3; KRT6C; EVPLL; PPL; DSP;	GO:0045104~intermediate filament cytoskeleton organization	7	22	31.8181818181818	0.00675697549456622	0.50736072517895	1	1	0.999999999042763	0.999999999042763	1
up	OPRM1; IL31RA; ELANE;	GO:0002438~acute inflammatory response to antigenic stimulus	3	8	37.5	0.0067921839380265	0.220011687830399	1	1	0.999999225924548	0.999999225924548	1
up	TLR9; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.0067921839380265	0.220011687830399	1	1	0.999999225924548	0.999999225924548	1
up	LTF; DEFA4; DEFA3;	GO:0051673~membrane disruption in other organism	3	8	37.5	0.0067921839380265	0.220011687830399	1	1	0.999999225924548	0.999999225924548	1
up	ELANE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.0067921839380265	0.220011687830399	1	1	0.999999225924548	0.999999225924548	1
up	JCHAIN; IGKC; IGHG3; IGHA2; LTF; CDH3;	GO:0001895~retina homeostasis	6	40	15	0.00692389736262033	0.221287759709346	1	1	0.999999225924548	0.999999225924548	1
up	ORM1; BPI; NCKAP1L; SLAMF1; TLR9;	GO:0032715~negative regulation of interleukin-6 production	5	29	17.2413793103448	0.0080604643085096	0.229476594568695	1	1	0.999999225924548	0.999999225924548	1
up	SPI1; IRF4; BATF; BATF3;	GO:0043011~myeloid dendritic cell differentiation	4	18	22.2222222222222	0.00819185834241409	0.229476594568695	1	1	0.999999225924548	0.999999225924548	1
down	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.00849998510538219	0.588990545086395	1	1	0.999999999042763	0.999999999042763	1
down	TGM1; TGM3; HRNR;	GO:0043163~cell envelope organization	3	3	100	0.00849998510538219	0.588990545086395	1	1	0.999999999042763	0.999999999042763	1
down	CXCL13; S100A8; GJA1; CCL11;	GO:0002544~chronic inflammatory response	4	7	57.1428571428571	0.00852620939615512	0.588990545086395	1	1	0.999999999042763	0.999999999042763	1
down	S100A8; SERPINB3; CX3CL1; HILPDA;	GO:0035425~autocrine signaling	4	7	57.1428571428571	0.00852620939615512	0.588990545086395	1	1	0.999999999042763	0.999999999042763	1
up	F13A1; IL2RA; FN1; PF4; FCER2; CSF3; OSM; LIF; ALOX15; OPRM1; FLT3; OPRD1; CCR2; FASLG; CCR5; IL5RA; IRF4; BATF; IFNL1; IL31RA;	GO:0019221~cytokine-mediated signaling pathway	20	278	7.19424460431655	0.00866412706695185	0.229476594568695	1	1	0.999999225924548	0.999999225924548	1
up	CSF3; SPI1; CEBPE;	GO:0030851~granulocyte differentiation	3	9	33.3333333333333	0.00880761230718397	0.229476594568695	1	1	0.999999225924548	0.999999225924548	1
up	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.00880761230718397	0.229476594568695	1	1	0.999999225924548	0.999999225924548	1
up	BPI; FCGR2B; IL31RA;	GO:0043031~negative regulation of macrophage activation	3	9	33.3333333333333	0.00880761230718397	0.229476594568695	1	1	0.999999225924548	0.999999225924548	1
up	IGHD; ORM1; ORM2;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.00880761230718397	0.229476594568695	1	1	0.999999225924548	0.999999225924548	1
up	TYROBP; IFNG; AZU1;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	3	9	33.3333333333333	0.00880761230718397	0.229476594568695	1	1	0.999999225924548	0.999999225924548	1
down	MT1X; MT1A; MT1H; MT4; MT1E; MT1B; MT1G; MT1M;	GO:0006882~cellular zinc ion homeostasis	8	30	26.6666666666667	0.0092605805483672	0.624063411635544	1	1	0.999999999042763	0.999999999042763	1
up	IL2RA; CTLA4; CLEC4G; LILRB2; LILRB1; PDCD1LG2;	GO:0042130~negative regulation of T cell proliferation	6	43	13.953488372093	0.0094096335601388	0.242525716598416	1	1	0.999999225924548	0.999999225924548	1
up	LTF; RNASE3; DEFA3; DEFA4;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.00962869089100782	0.245531617720699	1	1	0.999999225924548	0.999999225924548	1
down	MPZL2; CDH16; CEACAM5; DSG3; DSG1; CADM3; PCDH11X; ROBO2; CDH22; PCDHB8; PCDHB10; PCDHGB4; PCDHA7; PCDHA4; PCDHB5; PCDHGC4; PCDHA9; PCDHA8; PCDHAC2; CDH5; NECTIN4; CNTN4; CDH19; IGSF21; CDH12;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	25	165	15.1515151515152	0.00963265293407134	0.624063411635544	1	1	0.999999999042763	0.999999999042763	1
down	FGF10; TCF21; PDGFRA; HNF1B; FOXF1; OVOL2;	GO:0048557~embryonic digestive tract morphogenesis	6	18	33.3333333333333	0.0099764820994569	0.626523075845893	1	1	0.999999999042763	0.999999999042763	1
up	AVPR1A; NTRK2; P2RY12; NMUR1; GPR55;	GO:0007202~activation of phospholipase C activity	5	31	16.1290322580645	0.0102739556887426	0.257222867848851	1	1	0.999999225924548	0.999999225924548	1
up	FOLR2; CCR2; CCL26; XCL2; CCL24; XCL1;	GO:0002548~monocyte chemotaxis	6	44	13.6363636363636	0.0103636058557441	0.257222867848851	1	1	0.999999225924548	0.999999225924548	1
up	LTF; MS4A1; CCR2; CCR6; JCHAIN; IFNG; AIRE;	GO:0006959~humoral immune response	7	58	12.0689655172414	0.0104091022867495	0.257222867848851	1	1	0.999999225924548	0.999999225924548	1
up	IL18RAP; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	3	10	30	0.0111361846295113	0.268934161658236	1	1	0.999999225924548	0.999999225924548	1
up	CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	3	10	30	0.0111361846295113	0.268934161658236	1	1	0.999999225924548	0.999999225924548	1
up	CCL24; HRH1; XCL1; XCL2;	GO:0048245~eosinophil chemotaxis	4	20	20	0.0112196145873273	0.268934161658236	1	1	0.999999225924548	0.999999225924548	1
up	DBH; LIF; CCR2; CRB1; SEMA3C;	GO:0001974~blood vessel remodeling	5	32	15.625	0.0115227733400789	0.273466214813556	1	1	0.999999225924548	0.999999225924548	1
down	IL20RB; IL1A; IL36A; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	7	25	28	0.0118079811634544	0.701840290907583	1	1	0.999999999042763	0.999999999042763	1
down	CYP1A1; ADH1A; CYP2C9; UGT1A1; CYP2C19; FMO2; UGT1A7;	GO:0017144~drug metabolic process	7	25	28	0.0118079811634544	0.701840290907583	1	1	0.999999999042763	0.999999999042763	1
down	GJB6; GJB1; GJA1; GJB2;	GO:0016264~gap junction assembly	4	8	50	0.0119885863241307	0.701840290907583	1	1	0.999999999042763	0.999999999042763	1
down	MT1A; MT1E; MT1G; AKR1C3; MT1H; MT1X; MT1M; MT4; MT1B;	GO:0071276~cellular response to cadmium ion	9	39	23.0769230769231	0.0128046402061549	0.737120454534317	1	1	0.999999999042763	0.999999999042763	1
up	GPR55; GPR174; GPR65; F2RL3; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	5	33	15.1515151515152	0.012870915227624	0.281148401563319	1	1	0.999999225924548	0.999999225924548	1
up	TYROBP; IFNG; AZU1; CCR2;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	4	21	19.047619047619	0.0129702124091924	0.281148401563319	1	1	0.999999225924548	0.999999225924548	1
up	XCL1; NCKAP1L; XCL2; CXCR1; PF4; CCL26; PF4V1; CCL24;	GO:0030593~neutrophil chemotaxis	8	76	10.5263157894737	0.0130193878070624	0.281148401563319	1	1	0.999999225924548	0.999999225924548	1
up	ELANE; CCR6; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.0137857903294485	0.284866719135242	1	1	0.999999225924548	0.999999225924548	1
up	CYP11B1; CRHBP; PPARGC1A;	GO:0035865~cellular response to potassium ion	3	11	27.2727272727273	0.0137857903294485	0.284866719135242	1	1	0.999999225924548	0.999999225924548	1
up	VIL1; LMOD2; SCIN;	GO:0045010~actin nucleation	3	11	27.2727272727273	0.0137857903294485	0.284866719135242	1	1	0.999999225924548	0.999999225924548	1
up	ELANE; CTSG; IFNL1;	GO:0050778~positive regulation of immune response	3	11	27.2727272727273	0.0137857903294485	0.284866719135242	1	1	0.999999225924548	0.999999225924548	1
down	SPDEF; SOSTDC1; NKX6-2;	GO:0010454~negative regulation of cell fate commitment	3	4	75	0.0139947579626036	0.767268158775126	1	1	0.999999999042763	0.999999999042763	1
down	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.0139947579626036	0.767268158775126	1	1	0.999999999042763	0.999999999042763	1
down	SOX18; OVOL2; SOX17;	GO:0060214~endocardium formation	3	4	75	0.0139947579626036	0.767268158775126	1	1	0.999999999042763	0.999999999042763	1
up	FN1; WNT1; INHBA; ITGB4; CCR2; HHEX; F2RL3;	GO:0009611~response to wounding	7	62	11.2903225806452	0.0142053553159053	0.291027664036111	1	1	0.999999225924548	0.999999225924548	1
down	CTAGE4; CTAGE1; CTAGE8; CTAGE3P; CTAGE6;	GO:0035459~vesicle cargo loading	5	14	35.7142857142857	0.0146726502490252	0.77347464043117	1	1	0.999999999042763	0.999999999042763	1
down	SCNN1A; SCNN1B; SCNN1G; CYP4A11; TFAP2B;	GO:0055078~sodium ion homeostasis	5	14	35.7142857142857	0.0146726502490252	0.77347464043117	1	1	0.999999999042763	0.999999999042763	1
up	LILRA5; CCL24; IFNG; SERPINE1; OSM; CCR2; TLR9; TLR7;	GO:0050729~positive regulation of inflammatory response	8	78	10.2564102564103	0.0148578282774156	0.299837791331635	1	1	0.999999225924548	0.999999225924548	1
down	CLDN7; TF; EPCAM; DUOXA2; CCL19; DUOX2;	GO:2000147~positive regulation of cell motility	6	20	30	0.0148769940259121	0.77347464043117	1	1	0.999999999042763	0.999999999042763	1
up	IFNG; SPI1; CEBPE; IL31RA;	GO:0030225~macrophage differentiation	4	22	18.1818181818182	0.0148855641086627	0.299837791331635	1	1	0.999999225924548	0.999999225924548	1
up	XPNPEP2; MMP23B; HP; LTF; CFI; ELANE; CTSG; CPB1; AZU1; GZMH; MMP8; KEL; GZMK; TMPRSS3; PRSS57; ASRGL1; PRSS41; SFRP1; ADAMTSL1; PRSS33; ADAMTS15; HTRA1; ADAMTS10; DPEP3; FBXO2; MMP17; PLAU;	GO:0006508~proteolysis	27	436	6.19266055045872	0.0155409660648903	0.310430797146184	1	1	0.999999225924548	0.999999225924548	1
up	CD300LD; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	5	35	14.2857142857143	0.0158780970719059	0.314543790755029	1	1	0.999999225924548	0.999999225924548	1
down	FGF10; GJB6; CLDN1; REN; PENK; SLPI; CYP1A1; S100A8; EDN1; SCGB1A1; SELE; GJA1; UGT1A1; GJB2; S100A7; PTGER1; PCK1; BDKRB1; S100A14; GNG12; NOS2;	GO:0032496~response to lipopolysaccharide	21	138	15.2173913043478	0.0159455813262456	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	APOA1; APOE; APOC1; APOA4;	GO:0010873~positive regulation of cholesterol esterification	4	9	44.4444444444444	0.0162361134866501	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	IL2RA; CTLA4; FCGR2B;	GO:0050777~negative regulation of immune response	3	12	25	0.0167620349515238	0.32665526649433	1	1	0.999999225924548	0.999999225924548	1
up	TERT; HMGA2; NR2E1;	GO:2000648~positive regulation of stem cell proliferation	3	12	25	0.0167620349515238	0.32665526649433	1	1	0.999999225924548	0.999999225924548	1
down	OVOL1; KRT9; TCF15; DHCR24; DACT2; ASCL4; TFAP2B; DSP;	GO:0043588~skin development	8	34	23.5294117647059	0.0168325262851369	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP2F1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	6	21	28.5714285714286	0.0178630908287991	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	ADCYAP1; ADCYAP1R1; SCTR; FFAR4; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	5	15	33.3333333333333	0.0183013765745547	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	PF4; CXCR5; CNR2; PF4V1;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.0192282998796974	0.340509849241322	1	1	0.999999225924548	0.999999225924548	1
up	PF4; IRF8; IRF4; BATF;	GO:0042832~defense response to protozoan	4	24	16.6666666666667	0.0192282998796974	0.340509849241322	1	1	0.999999225924548	0.999999225924548	1
up	LILRA5; IFNG; AIF1; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	5	37	13.5135135135135	0.0193197077583729	0.340509849241322	1	1	0.999999225924548	0.999999225924548	1
up	JCHAIN; IGKV3-20; IGHA2;	GO:0003094~glomerular filtration	3	13	23.0769230769231	0.0200684460386986	0.346072411185328	1	1	0.999999225924548	0.999999225924548	1
up	CD19; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.0200684460386986	0.346072411185328	1	1	0.999999225924548	0.999999225924548	1
up	SPTA1; VIL1; SCIN;	GO:0051693~actin filament capping	3	13	23.0769230769231	0.0200684460386986	0.346072411185328	1	1	0.999999225924548	0.999999225924548	1
down	CHP2; BMP2; RGN;	GO:0010922~positive regulation of phosphatase activity	3	5	60	0.0210725298485357	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	EDN1; EDN3; CPE;	GO:0030072~peptide hormone secretion	3	5	60	0.0210725298485357	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	APOC1; APOC3; CCDC3;	GO:0045833~negative regulation of lipid metabolic process	3	5	60	0.0210725298485357	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	CD1A; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	3	5	60	0.0210725298485357	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.0210725298485357	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	CIDEA; EDN2; DRD1; ACADL; NMU; ADRB3;	GO:0001659~temperature homeostasis	6	22	27.2727272727273	0.0212349838748661	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	PLAT; CST4; CSTA; CSTB; SERPINB3; CAMK2N1;	GO:0045861~negative regulation of proteolysis	6	22	27.2727272727273	0.0212349838748661	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	APOA1; APOE; APOC3; APOA4;	GO:0034378~chylomicron assembly	4	10	40	0.02131656168462	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	CD40LG; XCL1; TIGIT; TLR9;	GO:0032733~positive regulation of interleukin-10 production	4	25	16	0.0216632913756234	0.370906495909781	1	1	0.999999225924548	0.999999225924548	1
down	CXCL11; CXCL10; DRD1; APLNR; BDKRB1; CX3CL1; CXCL9;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	7	29	24.1379310344828	0.0221618086646328	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	MMP8; SCIMP; LILRB2; TLR9; TLR8; TLR7;	GO:0032755~positive regulation of interleukin-6 production	6	53	11.3207547169811	0.0222071122838289	0.377520908825091	1	1	0.999999225924548	0.999999225924548	1
down	EDN1; MIF; EDN2; PTGIS; PLA2G4F;	GO:0001516~prostaglandin biosynthetic process	5	16	31.25	0.0224747754598339	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	CSTA; CSTB; SERPINB3; SERPINB4; ECM1;	GO:0010466~negative regulation of peptidase activity	5	16	31.25	0.0224747754598339	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	LAMB3; LAMC2; NTNG1; LAMA3; LAMA1;	GO:0009888~tissue development	5	39	12.8205128205128	0.0232171656959288	0.391895698558922	1	1	0.999999225924548	0.999999225924548	1
up	MMP8; FCGR2B; PDCD1LG2;	GO:0032693~negative regulation of interleukin-10 production	3	14	21.4285714285714	0.0237066651193341	0.391895698558922	1	1	0.999999225924548	0.999999225924548	1
up	HBZ; EPB42; TAL1;	GO:0043249~erythrocyte maturation	3	14	21.4285714285714	0.0237066651193341	0.391895698558922	1	1	0.999999225924548	0.999999225924548	1
up	UPK3A; SLC12A3; SLC12A1;	GO:0055078~sodium ion homeostasis	3	14	21.4285714285714	0.0237066651193341	0.391895698558922	1	1	0.999999225924548	0.999999225924548	1
down	CDH16; DSG1; CDH22; PCDHB10; PCDHGB4; PCDHB5; CDH12; CDH5; CDH19;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	9	45	20	0.0264517209338542	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	UPK3A; EPB42; PDPN; CDH13; NCKAP1L; CDH3; CDH26; CDH11;	GO:0000902~cell morphogenesis	8	88	9.09090909090909	0.0269444805000277	0.397250742496654	1	1	0.999999225924548	0.999999225924548	1
up	RCVRN; CABP4; TRPC3; GPR88;	GO:0007602~phototransduction	4	27	14.8148148148148	0.0270757351772571	0.397250742496654	1	1	0.999999225924548	0.999999225924548	1
up	CDH26; CDH3; CDH11; CDH13;	GO:0044331~cell-cell adhesion mediated by cadherin	4	27	14.8148148148148	0.0270757351772571	0.397250742496654	1	1	0.999999225924548	0.999999225924548	1
down	KRT6A; KRT16; SERPINB5; CA9; TBX5;	GO:0002009~morphogenesis of an epithelium	5	17	29.4117647058824	0.027218127559492	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	APOA1; APOE; APOC1; APOC3; APOA4;	GO:0034375~high-density lipoprotein particle remodeling	5	17	29.4117647058824	0.027218127559492	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	S100A8; S100A9; SELE; CX3CL1;	GO:0002523~leukocyte migration involved in inflammatory response	4	11	36.3636363636364	0.0272657719092542	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	FUT1; FUT3; FUT2; FUT6;	GO:0036065~fucosylation	4	11	36.3636363636364	0.0272657719092542	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	ALOX15; CYGB; PPARGC1A;	GO:0019395~fatty acid oxidation	3	15	20	0.027676626615328	0.397250742496654	1	1	0.999999225924548	0.999999225924548	1
up	LIF; NCKAP1L; P2RY12;	GO:0033630~positive regulation of cell adhesion mediated by integrin	3	15	20	0.027676626615328	0.397250742496654	1	1	0.999999225924548	0.999999225924548	1
up	NLRP6; IRF4; TLR9;	GO:0034122~negative regulation of toll-like receptor signaling pathway	3	15	20	0.027676626615328	0.397250742496654	1	1	0.999999225924548	0.999999225924548	1
up	IFNG; IL2RA; CTLA4;	GO:0045589~regulation of regulatory T cell differentiation	3	15	20	0.027676626615328	0.397250742496654	1	1	0.999999225924548	0.999999225924548	1
up	PRKD1; LILRB1; PACSIN1;	GO:0045806~negative regulation of endocytosis	3	15	20	0.027676626615328	0.397250742496654	1	1	0.999999225924548	0.999999225924548	1
up	IFNG; FCER2; TLR9;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	3	15	20	0.027676626615328	0.397250742496654	1	1	0.999999225924548	0.999999225924548	1
up	TAL1; BATF; SFRP1;	GO:0060218~hematopoietic stem cell differentiation	3	15	20	0.027676626615328	0.397250742496654	1	1	0.999999225924548	0.999999225924548	1
up	FLRT2; CTNNA2; SCRT2;	GO:2001222~regulation of neuron migration	3	15	20	0.027676626615328	0.397250742496654	1	1	0.999999225924548	0.999999225924548	1
down	GLI2; HOXB1; BMP5; SOSTDC1; GRHL3; FOXJ1; TBX5;	GO:0007389~pattern specification process	7	31	22.5806451612903	0.0291684523771591	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	PLA2G10; PLA2G2A; PLA2G4F; PLA2G2F; PLA2G3; PLA2G5;	GO:0050482~arachidonic acid secretion	6	24	25	0.02921086335014	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	DSP; GRHL1; PERP;	GO:0002934~desmosome organization	3	6	50	0.0297552040756439	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	EDN1; EDN3; EDN2;	GO:0003100~regulation of systemic arterial blood pressure by endothelin	3	6	50	0.0297552040756439	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	GJB6; GJA1; GJB2;	GO:0010644~cell communication by electrical coupling	3	6	50	0.0297552040756439	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	SERPINB7; LUM; CX3CL1;	GO:0032914~positive regulation of transforming growth factor beta1 production	3	6	50	0.0297552040756439	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	GJB6; GJB2; GJB4;	GO:1990349~gap junction-mediated intercellular transport	3	6	50	0.0297552040756439	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	SLC26A4; CA4; CA6; HBA1; RHAG;	GO:0015701~bicarbonate transport	5	42	11.9047619047619	0.0299575824987328	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	CTSG; DEFA4; DEFA3; CLEC6A;	GO:0050832~defense response to fungus	4	28	14.2857142857143	0.0300577768866924	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	RCVRN; OPRD1; P2RX1; P2RY12;	GO:0051924~regulation of calcium ion transport	4	28	14.2857142857143	0.0300577768866924	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	CRHBP; RASD2; DRD3;	GO:0001963~synaptic transmission, dopaminergic	3	16	18.75	0.0319767244403941	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	CCR2; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	3	16	18.75	0.0319767244403941	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	TLR9; TLR8; TLR7;	GO:0034162~toll-like receptor 9 signaling pathway	3	16	18.75	0.0319767244403941	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	UPK3A; SLC12A3; SLC12A1;	GO:0055075~potassium ion homeostasis	3	16	18.75	0.0319767244403941	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	LIM2; CDH11; CDH3; CDH13; CDH26;	GO:0007043~cell-cell junction assembly	5	43	11.6279069767442	0.0324503314242954	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
down	HPGDS; GSTA1; AKR1C3; AKR1C2; PTGR1;	GO:0006693~prostaglandin metabolic process	5	18	27.7777777777778	0.0325522141447052	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	CXCL10; CCL1; S100A7; CXCL17; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	5	18	27.7777777777778	0.0325522141447052	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	VIL1; AIF1; LMOD2; CATIP;	GO:0030041~actin filament polymerization	4	29	13.7931034482759	0.0332259481341717	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	XCL1; LILRB1; PGLYRP2; PDCD1LG2;	GO:0032689~negative regulation of interferon-gamma production	4	29	13.7931034482759	0.0332259481341717	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	VIL1; MS4A1; GZMA; FCGR2B; CD79B; IL27; REG4; NLRP6;	GO:0009617~response to bacterium	8	92	8.69565217391304	0.0332822125917132	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
down	ADH1B; ADH1C; ADH1A; ADH7;	GO:0006069~ethanol oxidation	4	12	33.3333333333333	0.0341078920166289	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	EDN1; EDN3; EDN2; GPR62;	GO:0048016~inositol phosphate-mediated signaling	4	12	33.3333333333333	0.0341078920166289	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	FN1; LOX; ROPN1B; TLR8; TLR7;	GO:0001932~regulation of protein phosphorylation	5	44	11.3636363636364	0.0350685925451562	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
down	ACR; ADRB3; ADCYAP1; DRD1; LHCGR; CAP2; ADCY2; FSHR;	GO:0007190~activation of adenylate cyclase activity	8	40	20	0.0352855606525676	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	TYROBP; NTRK1; AIF1; P2RY12;	GO:0048678~response to axon injury	4	30	13.3333333333333	0.0365813459775917	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	PLAU; SERPINE1; FCGR2B;	GO:0010469~regulation of signaling receptor activity	3	17	17.6470588235294	0.0366039670162919	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	LYZL6; GZMA; GZMH;	GO:0019835~cytolysis	3	17	17.6470588235294	0.0366039670162919	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	GATA1; TAL1; KITLG;	GO:0035162~embryonic hemopoiesis	3	17	17.6470588235294	0.0366039670162919	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	GATA1; NCKAP1L; RHAG;	GO:0048821~erythrocyte development	3	17	17.6470588235294	0.0366039670162919	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	AIF1; P2RY12; CCL26;	GO:0050921~positive regulation of chemotaxis	3	17	17.6470588235294	0.0366039670162919	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	IFNG; APOA2; AZU1; FCGR2B; SIRPG;	GO:0050766~positive regulation of phagocytosis	5	45	11.1111111111111	0.0378135910661187	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
down	APOA4; NOS2; H2BFS; DEFB1; DEFA5;	GO:0002227~innate immune response in mucosa	5	19	26.3157894736842	0.0384931962618845	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	ALOX12B; PSAPL1; SPNS2; ACER1; ALOXE3;	GO:0006665~sphingolipid metabolic process	5	19	26.3157894736842	0.0384931962618845	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	WNT9B; PDGFRA; BMP5; LHCGR; DHCR24;	GO:0030539~male genitalia development	5	19	26.3157894736842	0.0384931962618845	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	APOC1; APOC3; NPC1L1; APOA4; APOA1;	GO:0042157~lipoprotein metabolic process	5	19	26.3157894736842	0.0384931962618845	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	TRAV27; RNASE2; RNASE3; DEFA4; DEFA3; RNASE6; PGLYRP2; LYZL6;	GO:0050830~defense response to Gram-positive bacterium	8	95	8.42105263157895	0.0386519706429919	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
down	CYP1A1; UGT1A7; UGT1A8;	GO:0009804~coumarin metabolic process	3	7	42.8571428571429	0.0400262722529636	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	AQP1; SCTR; AQP4;	GO:0009992~cellular water homeostasis	3	7	42.8571428571429	0.0400262722529636	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	NPR3; AQP1; AQP5;	GO:0030157~pancreatic juice secretion	3	7	42.8571428571429	0.0400262722529636	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	SLC22A3; SCTR; HTR4;	GO:0032098~regulation of appetite	3	7	42.8571428571429	0.0400262722529636	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	APOA1; APOE; APOC3;	GO:0032489~regulation of Cdc42 protein signal transduction	3	7	42.8571428571429	0.0400262722529636	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	IYD; DIO2; CRYM;	GO:0042403~thyroid hormone metabolic process	3	7	42.8571428571429	0.0400262722529636	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	3	7	42.8571428571429	0.0400262722529636	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	NUPR1; IL33; IL18;	GO:0150078~positive regulation of neuroinflammatory response	3	7	42.8571428571429	0.0400262722529636	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	SPINK1; SPINK6; SPINK5;	GO:1900004~negative regulation of serine-type endopeptidase activity	3	7	42.8571428571429	0.0400262722529636	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	PENK; CCK; GJA1;	GO:2000987~positive regulation of behavioral fear response	3	7	42.8571428571429	0.0400262722529636	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	LTF; BTNL3; BTN1A1; BTNL8;	GO:0001817~regulation of cytokine production	4	31	12.9032258064516	0.0401246112310497	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	IFNG; CCR2; IFNL1; IL31RA;	GO:0007259~receptor signaling pathway via JAK-STAT	4	31	12.9032258064516	0.0401246112310497	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	CD19; FLT3; PRKD1; P2RY12;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	4	31	12.9032258064516	0.0401246112310497	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	INHBA; GATA1; TAL1; NCKAP1L;	GO:0045648~positive regulation of erythrocyte differentiation	4	31	12.9032258064516	0.0401246112310497	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	CDC42EP2; FASLG; AIF1; IRF8; XCL1; XCL2; CCL24; CCL26;	GO:0071346~cellular response to interferon-gamma	8	96	8.33333333333333	0.0405632498762277	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	INHBA; GATA1; TAL1; SPI1; TRIM10;	GO:0030218~erythrocyte differentiation	5	46	10.8695652173913	0.0406863528355337	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	CYP11B1; AIF1; AVPR2; GPR150; AVPR1A;	GO:0032870~cellular response to hormone stimulus	5	46	10.8695652173913	0.0406863528355337	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	DNTT; P2RX1; TRPC3;	GO:0033198~response to ATP	3	18	16.6666666666667	0.0415541213954691	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	SERPINE1; CCR2; AIF1;	GO:0090026~positive regulation of monocyte chemotaxis	3	18	16.6666666666667	0.0415541213954691	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	RNASE2; RNASE3; RNASE6;	GO:0090501~RNA phosphodiester bond hydrolysis	3	18	16.6666666666667	0.0415541213954691	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
down	CCL2; AQP1; MUC17; ABCA12;	GO:0019725~cellular homeostasis	4	13	30.7692307692308	0.0418558653273593	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	CYP1A1; HNF1B; HNF4A; PCK1;	GO:0070365~hepatocyte differentiation	4	13	30.7692307692308	0.0418558653273593	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	DBH; HRH2; HRH1; DRD3; SYNPO;	GO:0008542~visual learning	5	47	10.6382978723404	0.0436877052266958	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
down	EDN1; EDN3; EDN2; HRC; NMU;	GO:0010460~positive regulation of heart rate	5	20	25	0.0450525774103938	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	PDGFRA; EPCAM; HNF4A; MESP1; SOX17;	GO:0023019~signal transduction involved in regulation of gene expression	5	20	25	0.0450525774103938	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	CCL11; CCL1; CX3CL1; CCL18; CCL2;	GO:0048245~eosinophil chemotaxis	5	20	25	0.0450525774103938	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	SFRP1; NLRP7; ADAMTS7; XCL2; XCL1; CCL26; CCL24;	GO:0071347~cellular response to interleukin-1	7	81	8.64197530864197	0.0459519251098011	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	GATA1; TAL1; CLEC1B;	GO:0030220~platelet formation	3	19	15.7894736842105	0.0468218471406822	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	FFAR3; TLR9; TLR7;	GO:0032722~positive regulation of chemokine production	3	19	15.7894736842105	0.0468218471406822	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
down	DEFB4A; DEFA5; LCE3C; LCE3A; PGLYRP4; PGLYRP3; CST11;	GO:0031640~killing of cells of other organism	7	35	20	0.047331626864517	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
down	GABRD; ADCYAP1; GABRB2; GRIK3; FGF14; GABRA4; GABRA5;	GO:0060078~regulation of postsynaptic membrane potential	7	35	20	0.047331626864517	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	CCL26; XCL2; CCL24; XCL1;	GO:0048247~lymphocyte chemotaxis	4	33	12.1212121212121	0.0477751152747868	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
down	CD5L; S100A8; S100A9; KRT16; BMP2; CCL2; MIF; SELE; BDKRB1; CSRP3; CARD18; ELF3; IL18; IL17A; ECM1; TRIL; NLRP10; IL17F; CCL19; RARRES2; IL1RL2; CYP4F11; NOX4; CCL11; IL36A; ACKR1; CCL1; CXCL13; CCL17; PTGER1; CCL14; GPR33; CXCL9; IL36G; IL1A; IL36RN; CCL22; CCL18; IL1F10; IL36B; FPR3; CX3CL1; CXCL11; CXCL10;	GO:0006954~inflammatory response	44	381	11.5485564304462	0.0479098052255644	0.783766185491626	1	1	0.999999999042763	0.999999999042763	1
up	FN1; ALOX15; CDH3; LOX; OPRM1; NLRP6; DCBLD2;	GO:0042060~wound healing	7	82	8.53658536585366	0.0483416252535652	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
up	SSTR3; CNR2; OPRM1; OPRD1; HRH1; HRH2;	GO:0007187~G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	6	65	9.23076923076923	0.0487754862569179	0.415931110804102	1	1	0.999999225924548	0.999999225924548	1
